1401 related articles for article (PubMed ID: 17383117)
1. The impact of ongoing illicit drug use on methadone adherence in illicit drug users receiving treatment for HIV in a directly observed therapy program.
Raffa JD; Grebely J; Tossonian H; Wong T; Viljoen M; Khara M; Mead A; McLean M; Duncan F; Petkau AJ; DeVlaming S; Conway B
Drug Alcohol Depend; 2007 Jul; 89(2-3):306-9. PubMed ID: 17383117
[TBL] [Abstract][Full Text] [Related]
2. The impact of benzodiazepine use on methadone maintenance treatment outcomes.
Brands B; Blake J; Marsh DC; Sproule B; Jeyapalan R; Li S
J Addict Dis; 2008; 27(3):37-48. PubMed ID: 18956528
[TBL] [Abstract][Full Text] [Related]
3. [Cocaine abuse in maintenance therapy with methadone in narcotic dependent patients].
Ortner R; Peternell A; Kraigher D; Schindler S; Topitz A; Fischer G
Wien Klin Wochenschr; 2001 Dec; 113(23-24):934-8. PubMed ID: 11802509
[TBL] [Abstract][Full Text] [Related]
4. Problem drinking in relation to treatment outcome among opiate addicts in methadone maintenance treatment.
Stenbacka M; Beck O; Leifman A; Romelsjö A; Helander A
Drug Alcohol Rev; 2007 Jan; 26(1):55-63. PubMed ID: 17364837
[TBL] [Abstract][Full Text] [Related]
5. Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: the role of methadone maintenance therapy.
Palepu A; Tyndall MW; Joy R; Kerr T; Wood E; Press N; Hogg RS; Montaner JS
Drug Alcohol Depend; 2006 Sep; 84(2):188-94. PubMed ID: 16542797
[TBL] [Abstract][Full Text] [Related]
6. Depression in methadone maintenance treatment patients: rate and risk factors.
Peles E; Schreiber S; Naumovsky Y; Adelson M
J Affect Disord; 2007 Apr; 99(1-3):213-20. PubMed ID: 17055063
[TBL] [Abstract][Full Text] [Related]
7. The impact of methadone or buprenorphine treatment and ongoing injection on highly active antiretroviral therapy (HAART) adherence: evidence from the MANIF2000 cohort study.
Roux P; Carrieri MP; Villes V; Dellamonica P; Poizot-Martin I; Ravaux I; Spire B;
Addiction; 2008 Nov; 103(11):1828-36. PubMed ID: 18778390
[TBL] [Abstract][Full Text] [Related]
8. Adherence to HIV treatment among IDUs and the role of opioid substitution treatment (OST).
Spire B; Lucas GM; Carrieri MP
Int J Drug Policy; 2007 Aug; 18(4):262-70. PubMed ID: 17689374
[TBL] [Abstract][Full Text] [Related]
9. Multimodal drug addiction treatment: a field comparison of methadone and buprenorphine among heroin- and cocaine-dependent patients.
Vigezzi P; Guglielmino L; Marzorati P; Silenzio R; De Chiara M; Corrado F; Cocchi L; Cozzolino E
J Subst Abuse Treat; 2006 Jul; 31(1):3-7. PubMed ID: 16814005
[TBL] [Abstract][Full Text] [Related]
10. Factors affecting the outcome of methadone maintenance treatment in opiate dependence.
Kamal F; Flavin S; Campbell F; Behan C; Fagan J; Smyth R
Ir Med J; 2007 Mar; 100(3):393-7. PubMed ID: 17491538
[TBL] [Abstract][Full Text] [Related]
11. Cocaine abuse sharply reduced in an effective methadone maintenance program.
Borg L; Broe DM; Ho A; Kreek MJ
J Addict Dis; 1999; 18(4):63-75. PubMed ID: 10631964
[TBL] [Abstract][Full Text] [Related]
12. Patterns of abstinence or continued drug use among methadone maintenance patients and their relation to treatment retention.
White WL; Campbell MD; Spencer RD; Hoffman HA; Crissman B; DuPont RL
J Psychoactive Drugs; 2014; 46(2):114-22. PubMed ID: 25052787
[TBL] [Abstract][Full Text] [Related]
13. Impact of drug abuse treatment modalities on adherence to ART/HAART among a cohort of HIV seropositive women.
Kapadia F; Vlahov D; Wu Y; Cohen MH; Greenblatt RM; Howard AA; Cook JA; Goparaju L; Golub E; Richardson J; Wilson TE
Am J Drug Alcohol Abuse; 2008; 34(2):161-70. PubMed ID: 18293232
[TBL] [Abstract][Full Text] [Related]
14. Gender differences and pregnant women in a methadone maintenance treatment (MMT) clinic.
Peles E; Adelson M
J Addict Dis; 2006; 25(2):39-45. PubMed ID: 16785218
[TBL] [Abstract][Full Text] [Related]
15. Gender differences among HIV-positive methadone maintenance patients enrolled in a medication adherence trial.
Haug NA; Sorensen JL; Lollo ND; Gruber VA; Delucchi KL; Hall SM
AIDS Care; 2005 Nov; 17(8):1022-9. PubMed ID: 16176898
[TBL] [Abstract][Full Text] [Related]
16. A preliminary, controlled investigation of magnesium L-aspartate hydrochloride for illicit cocaine and opiate use in methadone-maintained patients.
Margolin A; Kantak K; Copenhaver M; Avants SK
J Addict Dis; 2003; 22(2):49-61. PubMed ID: 12703668
[TBL] [Abstract][Full Text] [Related]
17. Predictors of retention in methadone programs: a signal detection analysis.
Villafranca SW; McKellar JD; Trafton JA; Humphreys K
Drug Alcohol Depend; 2006 Jul; 83(3):218-24. PubMed ID: 16384657
[TBL] [Abstract][Full Text] [Related]
18. Behavioral contingencies improve counseling attendance in an adaptive treatment model.
Brooner RK; Kidorf MS; King VL; Stoller KB; Peirce JM; Bigelow GE; Kolodner K
J Subst Abuse Treat; 2004 Oct; 27(3):223-32. PubMed ID: 15501375
[TBL] [Abstract][Full Text] [Related]
19. Predictors of methadone maintenance treatment utilization in a multisite cohort of illicit opioid users (OPICAN).
Fischer B; Cruz MF; Patra J; Rehm J
J Subst Abuse Treat; 2008 Apr; 34(3):340-6. PubMed ID: 17614236
[TBL] [Abstract][Full Text] [Related]
20. Zopiclone misuse: an update from Dublin.
Bannan N; Rooney S; O'connor J
Drug Alcohol Rev; 2007 Jan; 26(1):83-5. PubMed ID: 17364840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
